TP53 and non-small cell lung carcinoma: Combined with previous findings, this suggests that TP53 is upstream of miR-424-5p and up-regulates SOCS5 and SOCS6 expression to inhibit JAK2/STAT3 and PI3K/AKT pathways activity, which alleviates NSCLC growth and DDP resistance.